Partner and Head of the Lidings’ Intellectual Property practice Boris Malakhov will take part in an annual conference entitled Intellectual Property - 2025 organized by Pravo.ru. The conference will take place on 21 November 2025 in Baltschug Kempinski.

The final of the annual All-Russian competition for court battles and public speaking, the Kutafin Legal Cup, will be held on November 15 at the O.E. Kutafin Moscow State Law University (MSAL).

It is a particular honor for us to curate the Pharmaceutical Law track - an area in which we possess deep practical expertise.

On October 22nd, an online discussion will take place, focusing on the operations of Russian businesses in the Middle East and North Africa (MENA) countries under sanctions pressure. The event is organized by the Legal Insight magazine and the Russian Export Center.

Dmitry Kirillov, Partner, Head of Tax and Customs practice at Lidings, will moderate the discussion session "Disputes with Tax Authorities or Defense in Tax Disputes".

Currently, the efforts of state authorities in the fields of pharmaceuticals and healthcare are also aimed at implementing the Strategy for the Development of the Pharmaceutical Industry of the Russian Federation for the Period up to 2030 (hereinafter referred to as the “Pharma 2030 Strategy”). One of the goals of the Pharma 2030 Strategy is to increase the share of domestically produced medicinal products in the total consumption volume from 61.8% to 66.6% by 2030. In this regard, measures to support Russian medicinal products manufacturers continue to be implemented.

On August 7, 2025, a draft law “On Amending the Federal Law ‘On Protection of Competition’” (hereinafter, the “Draft Law”) was published. Prepared by the Federal Antimonopoly Service (hereinafter, the “FAS”), it aims to significantly narrow the scope of antitrust immunities concerning the results of intellectual activity.

On 1 September 2025, a draft resolution of the Government of the Russian Federation “On approving the procedure and criteria for compiling a list of strategically significant medicines” (“Draft Resolution”) was submitted for public discussion.

Alina Smakova, Lidings associate specializing in personal data protection issues, will speak on the topic "Cross-Border Transfer of Personal Data: Building Bridges, Not Walls. Organizing Legal Cross-Border Data Flows".